The I150V polymorphism of GSTP1 with a phenotype of reduced enzymatic capacity has been correlated with better therapeutic outcomes in gastric cancer patients receiving oxaliplatin‐based chemotherapy.68, 69. The gene discussed is GSTP1; the disease is gastric cancer.